PRLog - May 10, 2011 - CAMBRIDGE, U.K. -- The joint developers of Chesterford Research Park, Aviva Investors and The Churchmanor Estates Company plc are delighted to announce the appointment of Savills as commercial agents for Chesterford Research Park. The appointment comes hot on the heels of news that construction of the new Science Village development at the Park, which is located within the South Cambridge biotech cluster, is now underway.
Chesterford Research Park and Savills Team
Martin Sylvester, Director of The Churchmanor Estates Company plc commented of the appointment:
The Science Village development is a multi-million pound speculative development which will total 33,700 sq ft - providing 28,000 sq ft of highly flexible, energy efficient, state-of-the-
Rob Sadler, Commercial Director at Savills, Cambridge, said: "We are delighted to be so closely involved with this new era at Chesterford. This is an environment designed to nurture, providing first class scientific facilities backed by excellent, flexible conferencing arrangements and well executed space for relaxation and leisure. The range of buildings available offers scope for established companies to relocate to this burgeoning centre, as well as opportunities for newer, up and coming players to become part of this technological community."
Chesterford Research Park (http://www.chesterfordresearchpark.com) provides a unique range of facilities and an excellent working environment for some of the more established pioneers in R&D such as Illumina and Biofocus, as well as the innovative newer breed of biotechnology companies such as Cellzome and Isogenica. Impressive Park facilities, which include meeting and conferencing space, a restaurant and fully equipped gym within The Nucleus building complement the state-of-the-
Chesterford Research Park is ideally situated within easy reach of the City of Cambridge, Stansted airport and the M11. The Park also operates a taxi service and regular shuttle buses to and from the railway station at Audley End, from which London is only an hour away. From its position within the South Cambridge Biotech Cluster, Chesterford Research Park is perfectly positioned to offer companies of all sizes attractively located, state-of-the-
# # #
Chesterford Research Park is being developed as a 250 acre low density scheme to provide high quality accommodation in an attractive environment for science and technology based companies of all sizes. To date, more than 240,000 sq ft of laboratory and R&D space has been let and occupied. Further phases of construction will extend the development to approximately 600,000 sq ft (56,500 sq m). The park is being developed as a joint venture between Aviva Investors and The Churchmanor Estates Company Plc. http://www.chesterfordresearchpark.com and http://www.thenucleus.uk.com